Analyst Recommendations For Rocket Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analyst recommendations for rocket pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analyst Recommendations For Rocket Pharmaceuticals Today - Breaking & Trending Today

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price […] ....

United States , John Militello , Mark Andrew White , Rocket Pharmaceuticals Inc , Allspring Global Investments Holdings , Torray Investment Partners , Rocket Pharmaceuticals Company Profile , Analyst Recommendations For Rocket Pharmaceuticals , Jpmorgan Chase Co , News Ratings For Rocket Pharmaceuticals Daily , Institutional Investors Weigh In On Rocket Pharmaceuticals , Rocket Pharmaceuticals , Rocket Pharmaceuticals Stock Performance , Securities Exchange Commission , Principal Financial Group Inc , Needham Company , Cantor Fitzgerald , Get Free Report , Exchange Commission , Global Investments Holdings , Financial Group , Investment Partners , Teacher Retirement System , Retirement System , Get Free , Rocket Pharmaceuticals Daily ,

Needham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)

Needham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Davidp Southwell , Zurcher Kantonalbank Zurich Cantonalbank , Hedge Funds Weigh In On Rocket Pharmaceuticals , Cantor Fitzgerald , Allspring Global Investments Holdings , Mirae Asset Global Investments Co , News Ratings For Rocket Pharmaceuticals Daily , Analyst Recommendations For Rocket Pharmaceuticals , Td Asset Management Inc , Jpmorgan Chase Co , Rocket Pharmaceuticals Trading Down , Insider Transactions At Rocket Pharmaceuticals , Rocket Pharmaceuticals , Needham Company , Goldman Sachs Group , Rocket Pharmaceuticals Inc , Securities Exchange Commission , York Mellon Corp , Get Free Report , Pharmaceuticals Trading Down , Director David , Exchange Commission , New York Mellon Corp , Kantonalbank Zurich Cantonalbank , Asset Global Investments , Management Inc ,

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by Brokerages

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New Zealand General , New Zealand , Gotham Makker , Davidp Southwell , Wellington Management Group , Vanguard Group Inc , Rocket Pharmaceuticals Price Performance , Cantor Fitzgerald , Institutional Trading Of Rocket Pharmaceuticals , Goldman Sachs Group , Westfield Capital Management Co , Insider Transactions At Rocket Pharmaceuticals , Jpmorgan Chase Co , Securities Exchange Commission , Needham Company , Rocket Pharmaceuticals , Comerica Bank , Rocket Pharmaceuticals Inc , Analyst Recommendations For Rocket Pharmaceuticals , News Ratings For Rocket Pharmaceuticals Daily , Get Free Report , Director Gotham Makker , Exchange Commission , Director David , Management Group , Capital Management ,

Rocket Pharmaceuticals (NASDAQ:RCKT) Receives New Coverage from Analysts at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report published on Tuesday, MarketBeat Ratings reports. The firm issued a neutral rating and a $39.00 price target on the biotechnology company’s stock. RCKT has been the topic of several other reports. UBS Group cut their price objective […] ....

Kinnari Patel , Gotham Makker , Jpmorgan Chase Co , Steward Partners Investment Advisory , Analyst Recommendations For Rocket Pharmaceuticals , Wells Fargo Company , Life Insurance Co , China Universal Asset Management Co , Rocket Pharmaceuticals Inc , Needham Company , Advisor Group Holdings Inc , Rocket Pharmaceuticals , Goldman Sachs Group , Rocket Pharmaceuticals Stock Down , Institutional Investors Weigh In On Rocket Pharmaceuticals , News Ratings For Rocket Pharmaceuticals Daily , Free Report , Marketbeat Ratings , Moderate Buy , Pharmaceuticals Stock Down , Get Free Report , Director Gotham Makker , Group Holdings , Partners Investment Advisory , Universal Asset Management , Rocket Pharmaceuticals Daily ,

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $54.00 Average Price Target from Analysts

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $54.00 Average Price Target from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Gotham Makker , Gaurav Shah , Jpmorgan Chase Co , Rocket Pharmaceuticals Stock Performance , Rocket Pharmaceuticals Company Profile , Cantor Fitzgerald , Rocket Pharmaceuticals , Institutional Investors Weigh In On Rocket Pharmaceuticals , News Ratings For Rocket Pharmaceuticals Daily , Goldman Sachs Group , Rocket Pharmaceuticals Inc , Analyst Recommendations For Rocket Pharmaceuticals , Synovus Financial Corp , Metlife Investment Management , Hightower Advisors , Get Free Report , Lifesci Capital , Director Gotham Makker , Tower Advisors , Life Investment Management , Financial Corp , Get Free , Rocket Pharmaceuticals Daily ,